These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 3658997)

  • 1. The value of prognostic factors in prostatic cancer.
    Schubert J; Kowalik S
    Int Urol Nephrol; 1994; 26(5):541-7. PubMed ID: 7860202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Importance of determining steroid hormone receptors and the treatment of prostatic cancer].
    Fedotov IA; Denisov LE; Kozlov VP; Degtiar' VG
    Urol Nefrol (Mosk); 1983; (1):63-70. PubMed ID: 6187115
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormonal receptors and other procedures for predicting clinical response in cancer of the prostate].
    Habib FK; Chisholm GD
    Arch Esp Urol; 1984 Dec; 37 Suppl 2():751-9. PubMed ID: 6085672
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer.
    Nishiyama T; Hashimoto Y; Takahashi K
    Clin Cancer Res; 2004 Nov; 10(21):7121-6. PubMed ID: 15534082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Punch biopsy tissue: enzyme and receptor analyses as criteria for hormone responsiveness in the treatment of prostatic cancer--limitations.
    Bartsch G; Janetschek G; Daxenbichler G; Dietze O; Mikuz G
    Prog Clin Biol Res; 1987; 243A():101-10. PubMed ID: 3658997
    [No Abstract]   [Full Text] [Related]  

  • 6. Uses and limitations of hormone, receptor and enzyme assays in prostate cancer.
    Martin PM; Le Goff JM; Brisset JM; Ojasoo T; Husson JM; Raynaud JP
    Prog Clin Biol Res; 1987; 243A():111-40. PubMed ID: 3309969
    [No Abstract]   [Full Text] [Related]  

  • 7. A critical evaluation of the use of androgen receptor assays to predict the androgen responsiveness of prostatic cancer.
    Barrack ER; Tindall DJ
    Prog Clin Biol Res; 1987; 239():155-87. PubMed ID: 3309954
    [No Abstract]   [Full Text] [Related]  

  • 8. Acceptor sites: genomic sites for androgenic regulation of prostatic growth.
    Rennie PS
    Prog Clin Biol Res; 1987; 239():189-203. PubMed ID: 3309955
    [No Abstract]   [Full Text] [Related]  

  • 9. Androgen receptor assays in advanced prostatic cancer.
    Buttyan R; Olsson CA
    Urol Clin North Am; 1984 May; 11(2):311-7. PubMed ID: 6375068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid receptor and biochemical profiles in prostatic cancer: correlation with response to hormonal treatment.
    Barrack ER; Brendler CB; Walsh PC
    Prog Clin Biol Res; 1987; 243A():79-97. PubMed ID: 3309976
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.